StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories effective Tax Rate — GAAP Reported (%) (%)

Form 8-K Q&A / Tax Rate Table & Form 10-K Tax Footnote

Latest, FY2025
22.9%
Period ended Dec 31, 2025
Change on a year earlier
+114.0 pts
-91.1% in FY2024
History
13 years
Since FY2013
Sources
12
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEffective Tax Rate — GAAP Reported (%) (%)Year on yearSource
FY2025Dec 31, 202522.9%+114.0 ptsSEC Filing (0001628280-26-002982) ↗
FY2024Dec 31, 2024-91.1%-105.2 ptsSEC Filing (0001628280-26-002982) ↗
FY2023Dec 31, 202314.1%-2.4 ptsSEC Filing (0001628280-25-002092) ↗
FY2022Dec 31, 202216.5%+2.6 ptsSEC Filing (0001628280-24-002009) ↗
FY2021Dec 31, 202113.9%+3.9 ptsSEC Filing (0001628280-23-001516) ↗
FY2020Dec 31, 202010.0%+0.4 ptsSEC Filing (0001104659-22-007648) ↗
FY2019Dec 31, 20199.6%-9.2 ptsSEC Filing (0001104659-21-007942) ↗
FY2018Dec 31, 201818.8%-65.4 ptsSEC Filing (0001104659-20-005717) ↗
FY2017Dec 31, 201784.2%+59.4 ptsSEC Filing (0001104659-19-002848) ↗
FY2016Dec 31, 201624.8%+6.7 ptsSEC Filing (0001104659-18-003691) ↗
FY2015Dec 31, 201518.1%-13.6 ptsSEC Filing (0001104659-17-003920) ↗
FY2014Dec 31, 201431.7%+29.1 ptsSEC Filing (0001104659-16-091861) ↗
FY2013Dec 31, 20132.6%–SEC Filing (0001047469-16-010246) ↗

Cite this data

StockData. (2026). Abbott Laboratories Effective Tax Rate — GAAP Reported (%) (%), annual FY2013–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/tax-rate-gaap

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.